From basic biology to randomized clinical trial: The beta radiation for arteriovenous graft outflow stenosis (BRAVO II)

Prabir Roy-Chaudhury, Perry Arnold, Jeff Seigel, Sanjay Misra

Research output: Contribution to journalArticle

7 Scopus citations

Abstract

The BRAVO-II study was a randomized controlled study of endovascular radiation therapy as compared to sham radiation therapy, following angioplasty of a thrombosed PRFE graft. The results did not show a benefit of endovascular radiation therapy, albeit in the context of an early termination of the study at less than 50% enrollment due to business reasons. Emphasis is laid on the fact that there may still be a role for radiation therapy in specific clinical settings associated with dialysis vascular access dysfunction.

Original languageEnglish (US)
Pages (from-to)227-232
Number of pages6
JournalSeminars in Dialysis
Volume26
Issue number2
DOIs
StatePublished - Mar 1 2013

ASJC Scopus subject areas

  • Nephrology

Fingerprint Dive into the research topics of 'From basic biology to randomized clinical trial: The beta radiation for arteriovenous graft outflow stenosis (BRAVO II)'. Together they form a unique fingerprint.

  • Cite this